Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature

Rachel G Simpson,1 Majid Moshirfar,2 Jason N Edmonds,2 Steven M Christiansen,2 Nicholas Behunin21The University of Arizona College of Medicine, Phoenix, AZ, USA; 2John A Moran Eye Center, The University of Utah School of Medicine, Salt Lake City, UT, USAPurpose: To evaluate the current United States...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Simpson RG, Moshirfar M, Edmonds JN, Christiansen SM, Behunin N
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/3828bb476ec24ed1bb917824a1722f10
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3828bb476ec24ed1bb917824a1722f10
record_format dspace
spelling oai:doaj.org-article:3828bb476ec24ed1bb917824a1722f102021-12-02T07:13:30ZLaser in situ keratomileusis in patients with collagen vascular disease: a review of the literature1177-54671177-5483https://doaj.org/article/3828bb476ec24ed1bb917824a1722f102012-11-01T00:00:00Zhttp://www.dovepress.com/laser-in-situ-keratomileusis-in-patients-with-collagen-vascular-diseas-a11441https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Rachel G Simpson,1 Majid Moshirfar,2 Jason N Edmonds,2 Steven M Christiansen,2 Nicholas Behunin21The University of Arizona College of Medicine, Phoenix, AZ, USA; 2John A Moran Eye Center, The University of Utah School of Medicine, Salt Lake City, UT, USAPurpose: To evaluate the current United States Food and Drug Administration (FDA) recommendations regarding laser in situ keratomileusis (LASIK) surgery in patients with collagen vascular diseases (CVD) and assess whether these patients make appropriate candidates for laser vision correction, and offer treatment recommendations based on identified clinical data.Methods: A literature search was conducted using PubMed, Medline, and Ovid to identify all existing studies of LASIK in patients with collagen vascular diseases. The search was conducted without date limitations. Keywords used for the search included MeSH terms: laser in situ keratomileusis, LASIK, refractive surgery, ocular surgery, and cataract surgery connected by "and" with the following MeSH and natural-language terms: collagen vascular disease, rheumatic disease, systemic disease, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, seronegative spondyloarthropathy, HLA B27, ankylosing spondylitis, reactive arthritis, psoriatic arthritis. The abstracts for all studies meeting initial search criteria were reviewed; relevant studies were included. No prospective studies were found; however, four retrospective case studies were identified that examined LASIK surgery in patients with CVD. Several case reports were also identified in similar fashion.Results: The FDA considers CVD a relative contraindication to LASIK surgery, due largely to the ocular complications associated with disease in the CVD spectrum. However, recent studies of LASIK in patients with CVD indicate LASIK may be safe for patients with very well-controlled systemic disease, minimal ocular manifestations, and no clinical signs or history of dry-eye symptoms.Conclusion: LASIK surgery may be safe in patients with rheumatoid arthritis or systemic lupus erythematosus and the seronegative spondyloarthropathies if stringent preoperative criteria are met. Evidence suggests patients with Sjögren's syndrome are not suitable candidates for LASIK.Keywords: refractive surgery, ocular surgery, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, seronegative spondyloarthropathiesSimpson RGMoshirfar MEdmonds JNChristiansen SMBehunin NDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2012, Iss default, Pp 1827-1837 (2012)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Simpson RG
Moshirfar M
Edmonds JN
Christiansen SM
Behunin N
Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature
description Rachel G Simpson,1 Majid Moshirfar,2 Jason N Edmonds,2 Steven M Christiansen,2 Nicholas Behunin21The University of Arizona College of Medicine, Phoenix, AZ, USA; 2John A Moran Eye Center, The University of Utah School of Medicine, Salt Lake City, UT, USAPurpose: To evaluate the current United States Food and Drug Administration (FDA) recommendations regarding laser in situ keratomileusis (LASIK) surgery in patients with collagen vascular diseases (CVD) and assess whether these patients make appropriate candidates for laser vision correction, and offer treatment recommendations based on identified clinical data.Methods: A literature search was conducted using PubMed, Medline, and Ovid to identify all existing studies of LASIK in patients with collagen vascular diseases. The search was conducted without date limitations. Keywords used for the search included MeSH terms: laser in situ keratomileusis, LASIK, refractive surgery, ocular surgery, and cataract surgery connected by "and" with the following MeSH and natural-language terms: collagen vascular disease, rheumatic disease, systemic disease, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, seronegative spondyloarthropathy, HLA B27, ankylosing spondylitis, reactive arthritis, psoriatic arthritis. The abstracts for all studies meeting initial search criteria were reviewed; relevant studies were included. No prospective studies were found; however, four retrospective case studies were identified that examined LASIK surgery in patients with CVD. Several case reports were also identified in similar fashion.Results: The FDA considers CVD a relative contraindication to LASIK surgery, due largely to the ocular complications associated with disease in the CVD spectrum. However, recent studies of LASIK in patients with CVD indicate LASIK may be safe for patients with very well-controlled systemic disease, minimal ocular manifestations, and no clinical signs or history of dry-eye symptoms.Conclusion: LASIK surgery may be safe in patients with rheumatoid arthritis or systemic lupus erythematosus and the seronegative spondyloarthropathies if stringent preoperative criteria are met. Evidence suggests patients with Sjögren's syndrome are not suitable candidates for LASIK.Keywords: refractive surgery, ocular surgery, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, seronegative spondyloarthropathies
format article
author Simpson RG
Moshirfar M
Edmonds JN
Christiansen SM
Behunin N
author_facet Simpson RG
Moshirfar M
Edmonds JN
Christiansen SM
Behunin N
author_sort Simpson RG
title Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature
title_short Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature
title_full Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature
title_fullStr Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature
title_full_unstemmed Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature
title_sort laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/3828bb476ec24ed1bb917824a1722f10
work_keys_str_mv AT simpsonrg laserinsitukeratomileusisinpatientswithcollagenvasculardiseaseareviewoftheliterature
AT moshirfarm laserinsitukeratomileusisinpatientswithcollagenvasculardiseaseareviewoftheliterature
AT edmondsjn laserinsitukeratomileusisinpatientswithcollagenvasculardiseaseareviewoftheliterature
AT christiansensm laserinsitukeratomileusisinpatientswithcollagenvasculardiseaseareviewoftheliterature
AT behuninn laserinsitukeratomileusisinpatientswithcollagenvasculardiseaseareviewoftheliterature
_version_ 1718399564293079040